Literature DB >> 1938218

Analysis of tissue ABH antigens in superficial bladder tumours.

H Tsujihashi1, H Matsuda, S Uejima, T Akiyama, T Kurita.   

Abstract

The determination of ABH blood group antigens for the prognosis of superficial bladder tumours was evaluated. A total of 114 cases of superficial bladder tumours were studied, and all cases were treated by transurethral resection (TUR). The 5-year recurrence rate was 42%. The ABH antigenicity provided more useful information than the grade in predicting recurrence of the tumours. The period from the initial TUR till the first recurrence in antigen-negative tumours was 17.5 months, which was shorter, though not significantly, than the corresponding period in antigen-positive tumours of 25.2 months. In addition, the presence or absence of isoantigens of tumours having two or more recurrences was examined individually.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1938218     DOI: 10.1007/bf02549726

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  23 in total

1.  The kinetics of cellular proliferation in rat urinary bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

2.  Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA).

Authors: 
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  ABO antigens in cancer. Detection with the mixed cell agglutination reaction.

Authors:  S Kovarik; I Davidsohn; R Stejskal
Journal:  Arch Pathol       Date:  1968-07

4.  Prognostic significance of ABH antigenicity of mucosal biopsies in superficial bladder cancer.

Authors:  G Das; N J Buxton; P A Stewart; R W Glashan
Journal:  J Urol       Date:  1986-12       Impact factor: 7.450

5.  The management of superficial bladder cancer.

Authors:  M S Soloway
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.

Authors:  J S Coon; A McCall; A W Miller; G M Farrow; R S Weinstein
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

7.  Detection of ABH antigens via exfoliated urinary cells. A preliminary report.

Authors:  H Tsujihashi; S Uejima; T Akiyama; T Kurita
Journal:  Urol Int       Date:  1987       Impact factor: 2.089

8.  Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  J Urol       Date:  1988-10       Impact factor: 7.450

9.  Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.

Authors:  E Cuadrado; A Rodriguez-Trinidad; E Blasco; J Torrado; J A Lopez Garcia; F Arozena
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450

10.  Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.

Authors:  R C Flanigan; C T King; T D Clark; J B Cash; B J Greenfield; I J Sniecinski; F J Primus
Journal:  J Urol       Date:  1983-09       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.